ARCHIVES

CMS Dares Critics To Produce ESA Data; House Bill Seeks To Vacate Coverage Decision.

This article is from The Cancer Letter archive.

Vol. 33 No. 35 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

It’s Official: House Appropriations Committee Gives NCI $81 Million Increase OverPresident’s Request

September 23, 1983

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

October 28, 2005

Funding Opportunities (12-page issue).

May 16, 2003